BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Genetown

  Kymera Therapeutics to Participate in Upcoming November 2023 Investor Conferences

  Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation, announced that the Company will participate at the following upcoming investor events.

  November 1, 2023

   · 

  5 min read
• Business

  C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

  C4 Therapeutics, Inc. reported financial results for the third quarter ended September 30, 2023, as well as recent business highlights.

  November 1, 2023

   · 

  12 min read
• Business

  EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments

  EyePoint Pharmaceuticals, Inc. announced financial results for the third quarter ended September 30, 2023, and highlighted recent corporate developments.

  November 1, 2023

   · 

  11 min read
• Pharm Country

  Tiziana Life Sciences to Present Recent Clinical Updates at BIO-Europe in Munich, Germany, November 6-8, 2023

  Tiziana Life Sciences Ltd. today announced that its Chief Operating Officer and Chief Medical Officer, Matthew Davis, MD, RPh, will present at BIO-Europe, Munich, Germany, November 6-8, 2023.

  November 1, 2023

   · 

  2 min read
• CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

  CollPlant Biotechnologies announced that the U.S. Patent and Trademark Office has granted a patent that covers CollPlant’s photocurable dermal filler product candidate, being developed for the aesthetics market.

  November 1, 2023

   · 

  5 min read
• Genetown

  PolyBio Research Foundation receives $15M for extended Long COVID research and clinical trials

  PolyBio Research Foundation has announced a $15M gift from Kanro: a philanthropic fund to support scientific research established by Vitalik Buterin , co-founder of Ethereum.

  November 1, 2023

   · 

  3 min read
• Business

  Avanos Medical, Inc. Announces Third Quarter 2023 Results

  Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2023 financial results.

  November 1, 2023

   · 

  27 min read
• Business

  cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer

  cTRL Therapeutics today announced the appointment of Derrell D. Porter, M.D., as Chief Executive Officer.

  November 1, 2023

   · 

  3 min read
• Drug Development

  KAZIA THERAPEUTICS PROVIDES PRELIMINARY UPDATE FROM ONGOING PHASE 2 STUDY OF PAXALISIB IN PRIMARY CNS LYMPHOMA

  Kazia Therapeutics Limited is pleased to provide a preliminary update from the ongoing investigator-initiated Phase 2 clinical trial (NCT04906096) evaluating paxalisib as monotherapy treatment in patients with relapsed/refractory primary central nervous system lymphoma (r/r PCNSL).

  November 1, 2023

   · 

  6 min read
• SIBIONICS Achieves Milestone: Receiving CE Mark for Its Groundbreaking GS1 Continuous Glucose Monitoring System

  SIBIONICS is delighted to announce that it has received the CE Mark for its revolutionary GS1 CGM.

  November 1, 2023

   · 

  2 min read